Covagen
	Operator of a biopharmaceutical company focused on therapies for inflammatory diseases and cancer. The company provides a proprietary platform that genetically fuses Fynomer binding proteins to antibodies, resulting in therapeutics with novel modes of action. The companyâ€™s first clinical drug candidate is designed for treatment of rheumatoid arthritis, psoriatic arthritis and other inflammatory diseases.
	['', 'inflammation binder', ' ', 'protein therapy', ' ', 'clinical drug', '']
Kanisa Pharmaceuticals
	Provider of oncology focused pharmaceutical services. The company is focused on developing new treatments for cancer with novel testing formats to stratify patients and predict likely responders to therapy.
	['', 'cancer treatment', ' ', 'pharmaceutical service', ' ', 'diagnosis service', '']
Cyrenaic Pharmaceuticals
	Developer of drugs for schizophrenia and bipolar disorder. The company is focused on the development of CYR-101, an innovative antipsychotic for the treatment of schizophrenia.
	['', 'schizophrenia treatment drug', ' ', 'bipolar disorder treatment', ' ', 'drug development', '']
Apalexo Biotechnologie
	Operator of a biopharmaceutical company focused on cancer treatment. The company is focused on development of a treatment to eradicate residual tumor cells following conventional cancer therapies.
	['immunotherapeutics cellular']
Arana Therapeutics
	Provider of biotechnology services. The company is focused on the development of antibody and peptide products for the treatment of inflammatory diseases and cancer.
	['', 'inflammatory diseases', ' ', 'peptide products', ' ', 'research services', '']
Oxxon Therapeutics
	Developer of novel immunotherapeutics. The company offers products for the treatment of chronic infectious diseases and cancer.
	['', 'chronic diseases', ' immunotherapeutics ', 'infectious diseases', '']
Nucleonics
	Provider of biotechnology services. The company is engaged in the development of novel RNA interference-based therapeutics for viral and other diseases.
	['', 'therapeutic products', ' ', 'biotechnology services', ' ', 'viral diseases', '']
Virxsys
	Provider of a biotechnology company. The company provides technology for the development of gene and vaccine therapies for the treatment of HIV, cancer and genetic diseases.
	['', 'vaccine therapy', ' ', 'genetic disease', ' ', 'biotechnology company', '']
Automated Cell
	Developer of antibody therapeutic antibodies for the treatment of oncology and immune disease. The company is focused on the development of monoclonal antibody therapeutics for the treatment of cancer.
	['', 'antibody therapeutic', ' ', 'therapeutic treatment', ' ', 'oncology disease', ' ', 'immune disease', ' ', 'monoclonal antibody', '']
